1 active trials 1 recruiting 3 disease areas 2 changes in 30 days
| Phase 1/2 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 1/2 | ||||
| NCT05267626 | Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in… | Advanced Solid Tumor | Recruiting | 2026-07-30 |
Non-Small Cell Lung Cancer (NSCLC) (1) · Lung Cancer (1) · Melanoma (1)